Status:
UNKNOWN
The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-65 years
Phase:
PHASE4
Brief Summary
The aim of this study is the comparison between the effects of supplementation with omega-3 or placebo for 10 weeks in type 2 diabetics
Detailed Description
Adipose tissue is recognized as an important endocrine organ in human. Not only it has function of storing unlimited energy but also its secretory roles is subject to intense research in recent years....
Eligibility Criteria
Inclusion
- literate
- Willingness to participation
- Diabetic patients 30-65 years old
- Body mass index in the range 18.5-40
- Avoidance of dietary supplements
- vitamins and herbal products at least 2 weeks before and throughout the intervention
Exclusion
- people who have used omega-3 supplements in last 3 months
- Having chronic renal disease
- hepatic disease
- gastrointestinal disease
- hematological disorders
- hypothyroidism or hyperthyroidism
- Treatment with Orlistat or sibutramine for weight loss
- Pregnancy and lactation
- Treatment with insulin or Thiazolidinediones
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01478776
Start Date
December 1 2011
End Date
September 1 2013
Last Update
December 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran University of Medical Sciences
Tehran, Tehran Province, Iran